Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

When developing drugs against SARS-CoV-2, it is important to consider the characteristics of patients with different co-morbidities. People infected with HIV-1 are a particularly vulnerable group, as they may be at a higher risk than the general population of contracting COVID-19 with clinical compl...

Full description

Bibliographic Details
Main Authors: Vladislav V. Fomenko, Nadezhda B. Rudometova, Olga I. Yarovaya, Artem D. Rogachev, Anastasia A. Fando, Anna V. Zaykovskaya, Nina I. Komarova, Dmitry N. Shcherbakov, Oleg V. Pyankov, Andrey G. Pokrovsky, Larisa I. Karpenko, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Molecules
Subjects:
human immunodeficiency virus type 1
SARS-CoV-2
entry inhibitors
nicotinates of glycyrrhizic acid
Online Access:https://www.mdpi.com/1420-3049/27/1/295

Internet

https://www.mdpi.com/1420-3049/27/1/295

Similar Items